ReviewCureus2025
Post-COVID-19 Barriers to Diabetic Retinopathy Screening Attendance: An Updated Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic retinopathy (DR) is a preventable cause of vision loss; with screening, there is the capability to recognise and treat the condition early. However, screening compliance remains sub-optimal, and the COVID-19 pandemic caused widespread disruptions to the screening programme. This review aims to update prior systematic reviews to identify barriers that remain, as well as identify new barriers that may have occurred due to the pandemic. Following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 guidelines, we searched seven databases (January 2020-July 2025) for English language primary studies on DR screening non-attendance, yielding 16 relevant studies across diverse regions. Key barriers fell into patient-related, health system, and environmental categories. Although there was evidence to suggest the same barriers remained, there is evidence to suggest the pandemic exacerbated prior barriers and introduced new barriers. These findings suggest the need for context-specific interventions to improve DR screening in the post-pandemic era.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.